Priligy dapoxetine is the first drug formulated to treat premature ejaculation in men. The drug has been classified as a type of short acting SSRI or selective serotonin reuptake inhibitor. From the description, priligy dapoxetine acts by inhibiting the serotonin transponder to cause a delay of ejaculation. And since it is only short acting, the priligy dapoxetine drug can be easily eliminated in the body making it an ideal treatment for premature climaxing. Originally, the drug content of priligy dapoxetine was intended to treat depression. However with it modified version to act only for a short time, it makes an ideal PE treatment but not as an antidepressant. The drug priligy dapoxetine was originally manufactured by Eli Lilly pharmaceuticals but was later sold to Johnson and Johnson company. Recently it has been marketed in Europe and Asia, and still on its way for approval in the United States.
What is PE?
PE or premature ejaculation is one of the sexual disorders in men wherein they fail to prolong climax leading to unsatisfactory sexual intercourse. Often times men are estimated to climax at more than 3 minutes. However climaxing less than this time could be a sign of premature ejaculation. Continue reading